Skip to main content

and
  1. No Access

    Article

    Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis

    Non-diabetic glomerulonephritis is a frequent cause of end-stage renal disease. The use of renin–angiotensin–aldosterone system blockers is a fundamental therapeutic approach. However, converting enzyme inhibi...

    Mariadelina Simeoni, Ramona Nicotera, Maria Colao in International Urology and Nephrology (2016)